Recalled Medical Devices Fast-Tracked Through FDA Approval Process Were Often Based on Flawed, Older Designs: Study
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Trial for Transvaginal Mesh Lawsuit Set to Begin Again on Monday July 25, 2013 Austin Kirk Add Your Comments Following a mistrial declared earlier this month, the first transvaginal mesh lawsuit in the federal court system is set to go before a new jury on Monday. The trial involves a product liability lawsuit brought by Donna Cisson against C.R. Bard, which alleges that Cisson suffered complications from Bard Avaulta mesh that was implanted transvaginally. The case will be the first out of more than 24,000 cases pending throughout the federal court system that involve different transvaginal mesh products. U.S. District Judge Joseph R. Goodwin declard a mistrial in the Cisson case on July 10, after a gynecological expert testified during the second day of trial that Bard has removed the Avaulta mesh from the market. A pretrial ruling excluded any mention of the subsequent withdraw of the product, which occurred long after the plaintiff’s injury. Learn More About Vaginal Mesh / Bladder Sling Lawsuits Complications from transvaginal mesh may cause severe injuries. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Vaginal Mesh / Bladder Sling Lawsuits Complications from transvaginal mesh may cause severe injuries. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The case will begin again on July 29, and it will be closely watched by product liability lawyers throughout the country who are involved in the transvaginal mesh litigation. Transvaginal Mesh Litigation Judge Goodwin is currently presiding over six different federal MDLs (Multi-District Litigations) involving different manufacturers of transvaginal mesh. According to an updated case list (PDF) released by the U.S. Judicial Panel on Multidistrict Litigation (JPML) on July 10, there are currently about 3,400 Bard Avaulta mesh lawsuits, 7,200 American Medical System (AMS) mesh lawsuits, 4,600 Boston Scientific mesh lawsuits, 7,100 Ethicon mesh lawsuits, 435 Coloplast bladder sling lawsuits and about 25 Cook Medical biologic mesh lawsuits. All of the complaints involve similar allegations that women experienced complications and other injuries after receiving transvaginal mesh for repair of pelvic organ prolapse (POP) or female stress urinary incontinence (SUI). Plaintiffs claim that manufacturers sold a dangerous and defectively designed product, which may be prone to erode through the vagina, cause infections and other debilitating health problems. The litigation has grown quickly over the past two years, following an FDA warning issued in July 2011 that indicated thousands of women have reported suffering problems with transvaginal mesh. The federal health regulators suggested that use of vaginal mesh to repair pelvic organ prolapse may provide no additional benefits over other treatment alternatives. In early 2012, the FDA sent a letter to several manufacturers of these products, ordering that they conduct additional studies and trials to evaluate the safety of transvaginal mesh products, looking for additional information to establish whether they pose an unreasonable risk of injury for women. Upcoming Trial Dates Cisson’s case is the first in a series of four trials involving Bard Avaulta mesh, which will begin consecutively. In addition, another series of “bellwether” trials are scheduled to begin in December 2013, involving products manufactured by AMS, Boston Scientific and Ethicon. These early trial dates are designed to help the parties gauge how juries are likely to respond to certain evidence and testimony that may be offered throughout the litigation. The prepartion and any verdicts may facilitate additional negotiations by the manufacturers to settle transvaginal mesh cases. In addition to lawsuits filed in the federal court system, there are also a number of complaints filed in various state courts throughout the country. At least two state court cases have already gone to trial, with a California jury awarding $5.5 million in damages in July 2012, and a New Jersey jury awarding $11.1 million in damages in February 2013. Tags: American Medical Systems (AMS), Bard, Bard Avaulta, Bard Avaulta Mesh, Bladder Sling, Boston Scientific, C. R. Bard, Ethicon, Gynecare, Gynecare Prolift, Johnson & Johnson, Transvaginal Mesh, Vaginal Mesh, Vaginal Sling More Vaginal Mesh Lawsuit Stories Study Finds Some Transvaginal Mesh Degrades Within 2 Months After It Is Implanted October 29, 2024 Supreme Court Rejects J&J Bid to Overturn $302M Vaginal Mesh Lawsuit Award February 23, 2023 Recalled Medical Devices Fast-Tracked Through FDA Approval Process Were Often Based on Flawed, Older Designs: Study January 16, 2023 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: yesterday) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025) Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: 2 days ago) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025) Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: 2 days ago) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)
Recalled Medical Devices Fast-Tracked Through FDA Approval Process Were Often Based on Flawed, Older Designs: Study January 16, 2023
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: yesterday) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: 2 days ago) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: 2 days ago) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)